SecBot SecBot
144 ·Filed Aug 14, 2026

KRYS

Krystal Biotech, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001958244-26-000513
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-proportional director sale with no material signal. Monitor for any follow-on Form 4 filings to confirm execution, but no trading action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$335.73
T+0 close · Aug 14, 2026 · via day close
Latest settled
−8.71%
T+60 · $306.50
Vs SPY
−5.76%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $335.73entry
  2. T+1 · 3mo ago −0.87%α −0.19% · $332.82
  3. T+5 · 3mo ago +1.78%α +2.97% · $341.72
  4. T+20 · 2mo ago +0.28%α +2.26% · $336.68
  5. T+60 · 7d ago −8.71%α −5.76% · $306.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Dino A. Rossi filed a Form 144 notice of intent to sell 25,000 shares of Krystal Biotech common stock through Goldman Sachs, with an estimated aggregate market value of approximately $8.3 million based on the filing date. This represents about 0.08% of the company's $9.7B market cap and a modest portion of Rossi's total holdings of ~29.6 million shares. The sale is routine for a director and does not signal insider concern given the small proportional size and the company's strong institutional support (89% analyst bullish).

Key Facts

  • Director Dino A. Rossi filed Form 144 to sell 25,000 shares of KRYS common stock.
  • Estimated aggregate market value of the proposed sale is approximately $8.3 million.
  • Rossi holds approximately 29.6 million shares post-sale, making this a ~0.08% reduction in his position.
  • The shares were acquired from the public market on 09/22/2017, indicating long-term holding.
  • Sale is to be executed through Goldman Sachs & Co. LLC.

Financial Impact

Proposed sale of 25,000 shares valued at ~$8.3 million, representing ~0.08% of KRYS's $9.7B market cap.

insider holdings

Risk Factors

  • Insider may still decide not to execute the sale despite filing the notice.
  • No material risk to the company's fundamentals or stock price from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000513
Document: 0001958244-26-000513-index.html0001958244-26-000513
Document: 0001958244-26-000513.txt0001958244-26-000513

Track record

18 reports on KRYS

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +26.60% at T+60 after the May 4, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $295.90 Now $297.90 +0.68% settles Dec 1
  3. Oct 30, 202617d ago SC 13G/A Bearish 5/10 Entry $332.29 Now $297.90 +10.35% settles Nov 30
  4. Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
  5. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
  6. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
  7. Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
  8. Oct 15, 20264w ago 8-K Bullish 6/10 Entry $330.00 to $305.68 Now $297.90 −9.73% ▼ −7.37% −5.47% vs SPY
  9. Sep 4, 202610w ago Insider Cluster Bearish 5/10 Entry $351.26 to $326.81 Now $297.90 +15.19% ▲ +6.96% +8.67% vs SPY
  10. Aug 14, 202613w ago 144 Neutral 2/10 Viewing Entry $335.73 to $336.68 Now $297.90 −11.27% ▲ +0.28% +2.26% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (11h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026